Averto Medical Awarded $2.1 Million NIH Grant to Advance Breakthrough Therapy for Diverticulitis
SAN FRANCISCO, Oct. 6, 2025 /PRNewswire/ — Averto Medical, a clinical-stage medical technology company pioneering gastrointestinal disease solutions, today announced it has been awarded a $2.1 million grant from the National Institutes of Health (NIH) to study its flagship product, the ColoSeal™ Intraluminal Colonic Diversion System, for a new indication: diverticulitis.
